“Can Re-CTURBT Be Useful in pT1HG Disease As a Risk Indicator of Recurrence and Progression? A Single Centre Experience”. Archivio Italiano Di Urologia E Andrologia, vol. 89, no. 4, Dec. 2017, pp. 272-6, https://doi.org/10.4081/aiua.2017.4.272.